Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2018 06:30 ET | Source: Histogenics Corporation

Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results

‒ Top-line Superiority Data from NeoCart® Phase 3 Clinical Trial and Potential Biologics License Application Submission on Track for Third Quarter of 2018 ‒‒ Initiation of Phase 3 Clinical Trial in...
May 09, 2018 16:05 ET | Source: Novavax, Inc.

Novavax Reports First Quarter 2018 Financial Results

GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent...
May 09, 2018 16:05 ET | Source: LifeVantage Corporation

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2018

Third Quarter Revenue Increased 12.3% Year over Year Raises Midpoint of 2018 Guidance Range for Adjusted Earnings Per Share 2018 Initiatives Driving Sequential Revenue Growth SALT LAKE CITY, May ...
May 09, 2018 16:00 ET | Source: Adverum Biotechnologies, Inc.

Adverum Biotechnologies Reports First Quarter 2018 Financial Results and Provides Corporate Update

MENLO PARK, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular...
May 09, 2018 10:36 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Announces Crowdfunding Financing Campaign to Support Food Allergy Treatment Research

New York, May 09, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics is pleased to announce the launch of a crowdfunding campaign on the Netcapital platform. This campaign supports the next steps of...
May 09, 2018 08:30 ET | Source: Arrayit Corporation

Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services

Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for...
May 09, 2018 08:30 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2018 Financial Results

NEWTOWN, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
May 09, 2018 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Results for the First Quarter of 2018

Key updates Eight out of twelve patients have been enrolled in a Phase 1/2 clinical trial of QR-110 in adults and children with LCA 10. Interim data are expected in the second half of 2018, with...
May 09, 2018 05:53 ET | Source: Crown Bioscience

CrownBio Menunjukkan Kelebihan Platform Onkologi Translasi Inovatif dalam Poster Saintifik pada Perjumpaan AACR 2018

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, syarikat subsidiari yang dimiliki sepenuhnya oleh Crown Bioscience International (TWSE:ticker 6554) dan syarikat perkhidmatan penemuan...
May 09, 2018 05:53 ET | Source: Crown Bioscience

CrownBio Menyajikan Keuntungan dari Platform Onkologi Translasional Inovatif di sesi Poster Ilmiah pada Pertemuan AACR 2018

SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, anak perusahaan yang dimiliki sepenuhnya oleh Crown Bioscience International (TWSE:ticker 6554) dan merupakan perusahaan jasa penemuan...